Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RAmU0YHpHOf6gCQB2VjtypjMKJ1VTjQ4mIu-QK1PbYjpw#assertion>. }
Showing items 1 to 10 of
10
with 100 items per page.
- association type Statement assertion.
- association label "maintenance of normal sinus rhythm delay in af afl recurrence dofetilide capsules are indicated for the maintenance of normal sinus rhythm delay in time to recurrence of atrial fibrillation atrial flutter af afl in patients with atrial fibrillation atrial flutter of greater than one week duration who have been converted to normal sinus rhythm because dofetilide can cause life threatening ventricular arrhythmias it should be reserved for patients in whom atrial fibrillation atrial flutter is highly symptomatic in general antiarrhythmic therapy for atrial fibrillation atrial flutter aims to prolong the time in normal sinus rhythm recurrence is expected in some patients see clinical studies conversion of atrial fibrillation flutter dofetilide capsules are indicated for the conversion of atrial fibrillation and atrial flutter to normal sinus rhythm dofetilide capsules have not been shown to be effective in patients with paroxysmal atrial fibrillation" assertion.
- association subject drugbank:DB00204 assertion.
- association predicate treats assertion.
- association object DOID_0060224 assertion.
- association relation TreatmentIndication assertion.
- DOID_0060224 category Disease assertion.
- drugbank:DB00204 category Drug assertion.
- association association_type ChemicalToDiseaseOrPhenotypicFeatureAssociation assertion.
- association provided_by NeuroDKG assertion.